Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>CANbridge Pharmaceuticals (02575.HK) Narrows Annual Loss to RMB246 Million
Recommend 3 Positive 3 Negative 3 |
||||
|
||||
|
CANbridge Pharmaceuticals (02575.HK) announced its annual results for the year ended last December, reporting revenue of RMB51.772 million, up 72% YoY. The loss narrowed to RMB246 million, compared to a loss of RMB556 million in the same period last year; LPS was RMB0.53. No dividend was declared. (hc/a) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
